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 Background: Kidney re-transplantation is a relevant option for patients who are returning to dialysis after graft failure. 
However, evidence is lacking to what extend a third kidney transplantation in the ipsilateral iliac fossa is safe 
and effective. The aim of this study was to investigate the outcomes of third kidney transplantations in the ip-
silateral iliac fossa compared to first and second ipsilateral fossa kidney transplantations.
 Material/Methods: There were 2074 kidneys transplanted at the Erasmus MC Rotterdam and at the University Medical Centre 
Groningen. Donor, recipient, and surgical data were collected. The cohort was divided into 3 groups: recipients 
of a first graft (I KTx; n=1744), recipients of a second graft (II KTx; n=44), and recipients of a third graft (III KTx; 
n=7).
 Results: Recipients from the II KTx group had a significantly higher rate of primary non-function (PNF) compared to re-
cipients in the I KTx group and recipients in the III KTx group (4.5% versus 0.7% and 0% respectively; P=0.006). 
The 1-year graft survival did not differ between groups: 96% for I KTx, 91% for II KTx, and 85% for III KTx 
(P=0.214). The 5-year graft survival did differ significantly between groups: 89% for I KTx, 82% for II KTx, and 
68% for III KTx (P=0.029). There were no differences regards hospital stay and rate of complications between 
groups.
 Conclusions: Third kidney transplantation in the ipsilateral iliac fossa is feasible and viable. Short-term results are compa-
rable to the first and the second kidney transplantation, however, long-term results are inferior but acceptable 
compared to dialysis.
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Background
Kidney transplantation provides the best long-term outcome 
for patients with end-stage kidney disease [1]. There is continu-
ous effort to increase the number of kidney transplantations by 
optimal utilization of donor kidneys. Kidney re-transplantation 
after graft loss is an option for patients returning to dialysis.
In general, little data on the results of kidney re-transplanta-
tion have been published showing contradictory findings. Most 
of the studies were case-control or cohort studies with a small 
number of cases. Moreover, long study inclusion times may 
cause significant biases due to changes in immunosuppres-
sion protocols over time, learning curve, variations in donor 
population, and the recipient complexity [2–4]. Some studies 
reported comparable or better outcomes of re-transplantation 
compared to the first transplantation [2,5–7], whereas others 
reported inferior outcomes of re-transplantation [3,8.9]. These 
studies mainly focused on graft and patient survival, while sur-
gical aspects were not studied extensively.
Re-transplantation in the ipsilateral iliac fossa can be a surgical 
challenge as has been reported previously [10]. Surgical risks of 
a third dissection of the iliac fossa include prolonged duration 
of surgery [3,4], prolonged second warm ischemia time (WIT-2), 
greater amount of blood loss [3], and an increased risk of iliac 
vessels injury, due to the postsurgical adhesions. Combined with 
more comorbidity and higher sensitization grade of the recipient 
[9] this may lead to worse kidney transplantation outcomes [11]. 
Nonetheless, cohort studies focusing on the outcomes of a third 
kidney transplantation in the same iliac fossa are lacking.
The aim of this study was to investigate the outcomes of a third 
kidney transplantation in the ipsilateral iliac fossa in compari-
son to first and second ipsilateral kidney transplantation with 
a special emphasis on the surgical complications.
Material and Methods
Study design and parameters of interest
A retrospective 2-center study was conducted of all consecu-
tive kidney transplant recipients (n=2074) who received kid-
ney transplantation between 2011–2016 at either the Erasmus 
MC Rotterdam or the University Medical Centre Groningen. 
The kidney transplant databases of these 2 centers were an-
alyzed and adult recipients who received a third or higher 
kidney transplantation in the ipsilateral fossa were extracted. 
Both deceased and living donor kidney transplantations were 
included. In case of re-transplantation(s), only the most recent 
transplantation was included in the analysis. Donor, recipient, 
and surgical data were collected and analyzed. The follow-up 
was until the 31st of July 2017 for all cases or until death or 
graft loss occurred. Baseline characteristics consisted of recip-
ient age, sex, and body mass index, type of donor (deceased 
or living), number of prior transplantations, number of veins 
and arteries of the donor kidney, side of surgery, cold ischemia 
time (CIT), WIT-2 and follow-up time (in months). The medical 
history of the recipient was collected and included the etiology 
of chronic kidney disease, dialysis modality (hemodialysis or 
peritoneal dialysis), history of hypertension and diabetes mel-
litus, as well as the anesthesiology risk classification according 
to the American Society of Anesthesiology. Immunologic data 
collected included blood group ABO-(in)compatibility, current 
and peak panel reactive antibodies (PRA) level, human leuko-
cytes antigen (HLA) mismatches, and numbers of positive cross-
match were collected and analyzed. Pediatric patients and pa-
tients with multiple organ transplantations were not included.
The cohort was divided into 3 groups: recipients of a first kid-
ney transplantation (I KTx) (n=1744), second kidney transplan-
tation to the ipsilateral iliac fossa (II KTx) (n=44) and third or 
subsequent kidney transplantation to the ipsilateral iliac fossa 
(III KTx) (n=7).
Short-term outcomes that were evaluated included operation 
time, estimated blood loss, the incidence of primary non-func-
tion (PNF) and delayed graft function (DGF), thrombotic events, 
bleeding events, urological complications, length of hospital 
stay, and the estimated glomerular filtration rate (eGFR) at 
3 months after transplantation calculated with the Chronic 
Kidney Disease Epidemiology Collaboration (CKD-EPI) formula. 
PNF was defined as permanent dependence on dialysis post-
transplantation. DGF was defined as the temporary need for di-
alysis starting the first week after kidney transplantation. PNF 
cases were not included in the DGF group. A bleeding event 
was defined as the need for red blood cells transfusion and/
or the need of surgical re-intervention because of bleeding. 
A thrombotic event was defined as the thrombosis of the re-
nal vein or renal artery of the kidney transplant diagnosed 
by imaging (ultrasound, nuclear scintigraphy, computed to-
mography) and confirmed during the surgical re-intervention. 
A urological complication was defined as the need for percu-
taneous nephrostomy placement or surgical re-intervention 
because of a urologic complication (ureteral stricture, urinary 
leakage). Long-term outcomes that were investigated included 
1-year and 5-year patient and non-death censored graft sur-
vival. Graft survival was defined as the time between the kid-
ney transplantation and date of graft failure (defined as re-
turn to hemodialysis or peritoneal dialysis return).
Surgical technique
Kidneys were routinely implanted in the iliac fossa. First, the re-
nal vein was anastomosed to the external iliac vein. The renal 
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artery was then anastomosed to the external iliac artery. All 
vascular anastomoses were performed in an end-to-side fash-
ion and with running sutures. In the II KTx group and the III KTx 
group, the vascular anastomoses were performed proximally or 
distally of the previous anastomosis. There was 1 case in the 
III KTx group when the cava vein and common iliac artery were 
used for the anastomosis, as a typical anastomosis was not pos-
sible. The anastomosis between donor ureter and recipient blad-
der was an extravesical anastomosis [10]. There was no case in 
which the previous transplant (in the II KTx group and the III KTx 
group) was implanted intraperitoneally. Immunosuppression of 
the recipients consisted of prednisolone, tacrolimus, mycophe-
nolate mofetil, and induction therapy with basiliximab.
Ethics
The study did not meet criteria for applying for the approval 
of the local or national ethics committee, as this is retrospec-
tive cohort study based on data from renal databases from 
2 transplant centers. The study complies with the Declaration 
of Helsinki and the Declaration of Istanbul.
Statistical analyses
Data is presented as frequencies for categorical variables 
and mean with standard deviation or median with range for 
continuous variables. One-way ANOVA or the Kruskal-Wallis 
tests were used for between-group comparisons as appropriate. 
Subsequent comparisons between 2 groups were done with 
Tukey’s post hoc test. Survival analysis was performed using 
the Kaplan-Meier method and Log rank test. The Cox propor-
tional hazard model was used to report hazard ratios of re-
transplantation for patient and graft survival. A P-value below 
0.05 was regarded as statistically significant. All data were an-
alyzed with statistical software SPSS version 21 for Windows.
Results
The baseline characteristics of these patients are depicted in 
Table 1. Fifty-one out of 2074 total kidney transplantations were 
identified as a third or subsequent adult transplant (2.5%). In 
this group, 7 recipients received third or subsequent kidney 
to the ipsilateral iliac fossa.
The recipients in the I KTx group were older (55±14 years) 
in comparison to other groups (P=0.031). Patients receiving 
a second or third kidney transplantation had a higher peak 
and current PRA. There were fewer living donor kidneys in the 










I vs. II I vs. III II vs. III
Mean age (years) (±SD) 55±14 46±17 46±11 .031 <.001 .218 1.00
Male sex (%, n)  61% (1055)  57% (25)  43% (3) .566
Median BMI (kg/m2)  26 (15–45)  24 (16–40)  21 (20–41) .082
Hypertension (%, n)  59.5 (1038)  31.8 (14)  42.9 (3) .791
Diabetes (%, n)  21.4 (374)  9.1 (4)  0.0 (0) .977
Haemodialysis (%, n)  49.4 (862)  45.5 (20)  42.9 (3) .525
Median ASA risk classification  3 (0–4)  3 (1–4)  3 (2–3) .989
Median HLA mismatches  3 (0–6)  3 (0–6)  2.5 (2–4) .700
Mean current PRA (%) (±SD)  10 (±3)  29 (±17)  36 (±11) <.001 <.001 <.001 <.001
Mean peak PRA (%) (±SD)  16 (±7)  42 (±44)  100 (±0) <.001 <.001 <.001 .056
Positive crossmatch (%, n)  0.06 (1)  0  0 .203
ABO-incompatible (%, n)  3.9 (69)  6.8 (3)  0 .227
Living donor (%, n)  61.0 (1064)  52.3 (23)  42.9 (3) .064
Table 1. Characteristic of the recipients of a first, second or third kidney transplanted to the same iliac fossa.
KTx – kidney transplantation; BMI – body mass index; ASA – American Society of Anaesthesiology; HLA – human leukocyte antigen; 
PRA – panel reactive antibody.
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Surgical aspects
There were no differences between the 3 groups with regard to 
the number of donor kidney arteries and veins (Table 2). There 
was a significantly longer CIT in the III KTx group in compari-
son to I KTx group (543 minutes versus 167 minutes; P=0.043). 
Median WIT 2 was shorter in the II KTx group in comparison 
to the I KTx group and the III KTx group (23 minutes versus 
29 minutes and 28 minutes, respectively), although significance 
was reached when the I KTx group and the II KTx group were 
compared (P=0.005). The mean duration of surgery was sig-
nificantly longer in the II KTx group and the III KTx group in 
comparison to the I KTx group (205 minutes versus 202 min-
utes versus 135 minutes respectively; P<0.001 and P=0.005). 
Median blood loss was significantly higher in the II KTx group 
and III KTx group in comparison to the I KTx group (438 and 
600 mL versus 200 mL respectively; P<0.001 and P=0.018).
In the III KTx group (7 cases), there was 1 kidney transplan-
tation (the fifth transplantation in the same patient and third 
transplantation to the same iliac fossa) performed intraper-
itoneally as the extra-peritoneal space was not accessible.
Short-term follow-up
There were no differences in the median hospital stay between 
groups (13 days, 14 days, and 18 days; P=0.943). Recipients 
in the II KTx group had a significantly higher rate of PNF com-
pared to the I KTx group and the III KTx group (4.5% versus 
0.7% versus 0%; P=0.006). Postoperative vascular and uro-
logical complications did not differ between groups. The me-
dian GFR at month 3 was similar between groups (Table 2).
Long-term follow-up
There were no differences in the median follow-up of the re-
cipients. One-year graft survival did not differ between groups: 
96% for the I KTx group, 91% for the II KTx group, and 85% 
for the III KTx group (P=0.214). The 5-year graft survival dif-
fered between groups: 89% for the I KTx group, 82% for the 
II KTx group, and 68% for the III KTx (P=0.029) (Figure 1). 
The 1-year and 5-year patient survival did not differ between 
groups: 97% and 91% for the I KTx group, 100% and 90% for 
the II KTx group, and 100% and 100% for the III KTx group 










I vs. II I vs. III II vs. III
Median number of transplants  1 (0)  3 (3–4)  4 (3–7) <.001 <.001 <.001 <.001
Right implantation side (%, n)  82.2 (1433)  54.5 (24)  85.7 (6) .779    
Median number of arteries  1 (1–5)  1 (1–3)  1 (0) .718    








.030 .495 .043 .165
Median WIT 2 (min)  29 (10–46)  23 (11–53)  28 (19–32) .006 .005 .733 .887
Mean operation time (min) (±SD) 135±41 205±67 202±19 <.001 <.001 .005 .991







<.001 <.001 .018 .896
Median hospital stay (days)  13 (8–143)  14 (7–27)  18 (8–27) .943    
PNF (%, n)  0.7 (12)  4.5 (2)  0 (0) .006 .004 .299 .976
DGF (%, n)  21.3 (371)  29.5 (13)  28.6 (2) .167    
Thrombotic events (%, n)  1.8 (31)  9.1 (4)  0 .926    
Bleeding events (%, n)  5.3 (93)  6.8 (3)  0 .798    
Urological complications (%, n)  0.6 (11)  2.3 (1)  0 .203    
Transplant nephrectomy (%, n)  1.0 (17)  2.3 (1)  0 .582    
Median 3 months GFR (ml/min)  47 (5–144)  52 (7–96)  46 (5–101) .419    
Median follow-up (months)  34 (0–83)  39 (0–82)  35 (6–80) .554    
Table 2. Intraoperative and short-term results of the first, second and third kidney transplanted to the same iliac fossa.
KTx – kidney transplantation; CIT – cold ischemia time; WIT 2 – second warm ischemia time (vascular anastomosis time); 
PNF – primary non-function; DGF – delayed graft function; GFR – glomerular filtration rate.
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The hazard ratios for graft and patient survival were calculated 
for the II KTx group and the III KTx group with the I KTx group 
as the reference group. No significant differences were found 
between the 3 groups (Table 3).
Discussion
In the present study, the results of the III KTx group in the ip-
silateral iliac fossa were studied and compared with the out-
comes of the IKTx group and the II KTx group in that same iliac 
fossa. Our main finding was that these outcomes were com-
parable, and the third kidney transplantation was a feasible 
and viable option for patients requiring a re-transplantation. 
Despite the longer duration of surgery and higher blood loss, 
the complication rate was the same compared to the first and 
second kidney transplantation. The median CIT was relatively 
short in all groups as living donors were a significant contri-
bution to donor pool (61.0% and 52.3% in the I KTx group and 
the II KTx group, respectively). The median CIT was significantly 
longer in the III KTx group in comparison to the I KTx group 
(543 minutes versus 167 minutes; P=0.043) which can be ex-
plained by the lowest rate of living donors in the donor pool 
(42.9%). The short-term outcomes were comparable. GFR was 
similar between the groups at 3 months post-transplantation 
(34 mL/min, 39 mL/min, and 35 mL/min in the I KTx group, 
the II KTx group, and the III KTx group, respectively, P=0.419). 
No differences were observed in patient survival at 1-year and 
5-years post-transplantation. Although 5-year graft survival 
was inferior (68% for the III KTx group versus 89% for the 
I KTx group and 82% for the II KTx; P=0.029), the next trans-
plantation to the same iliac fossa was not a risk factor for pa-
tient and graft survival.
To the best of our knowledge, there are no cohort studies re-
porting on third and subsequent kidney transplantations in 
the same iliac fossa. Mazzucchi et al. published a series of 
21 cases after third and subsequent kidney transplantation [3]. 
They did not report the numbers of explorations of the iliac 
fossa. In this series, 1 patient received a fifth kidney transplant, 
meaning that 1 of the iliac fossa was used for the third time 

































































































Graft survival Patient survival
HR p HR p
I KTx (control) 1.0 – 1.0 –
II KTx 1.97 0.080 1.09 0.881
III KTx 1.90 0.521 0.05 0.674
Table 3. The hazard ratio for graft and patient survival.
HR – hazard ratio; KTx – kidney transplantation.
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for the whole group and they needed more blood transfusions 
compared to the first kidney transplantation. These findings 
were similar to ours.
Kidney re-transplantation in the ipsilateral iliac fossa is surgi-
cally challenging. The transplant surgeon is forced to explore 
an iliac fossa with 2 previous dissections (the prior transplan-
tation and graft nephrectomy) in case of a second ipsilateral 
kidney re-transplantation and 4 previous dissections in the case 
of a third ipsilateral kidney re-transplantation. When there is 
atrophy of a previous graft, there is no necessity for graft ne-
phrectomy and the same iliac fossa can be used again. It can 
be assumed that the timing of kidney graft nephrectomy is 
important. If it is an early kidney graft removal (with kidney 
capsule), the iliac fossa may look similar to the native one. 
If it is a late graft nephrectomy (sub-capsular), more adhe-
sions may be expected in the iliac fossa. In our analyzed co-
hort of the III KTx group, all previous graft nephrectomies were 
done sub-capsular.
There is a lack of standards in management of patients for 
kidney re-transplantation due to the small numbers of re-
ported cases in the literature. Ott et al. reported a longer op-
eration time and higher surgical risk in third or fourth kid-
ney transplantations [4]. Kienzl-Wagner et al. published good 
short-term and long-term results after third and fourth kid-
ney transplantations [12]. Acute rejection was the predomi-
nant cause of graft loss in their series and the rate of surgical 
complications was on a reasonable level (7.1% severe com-
plications). Izquierdo et al. did not find differences in the pa-
tient and graft survival after third kidney transplantation in 
comparison to the second [13].
According to the published literature, there is no linear rela-
tionship between the number of transplantations and graft sur-
vival. Patients receiving a fourth or fifth kidney transplant can 
have a better graft survival in comparison to those receiving 
a second or third [9]. There are many factors affecting the re-
sults of the next kidney transplantation. Heaphy et al. under-
lined that the survival of the primary graft can predict the 
outcomes of the re-transplantation [14]. And it appears that 
a poorly functioning first transplantation results in a higher 
chance of worse outcome after re-transplantation. Blanco et al. 
published similar findings [6].
If an ipsilateral approach is impossible, several other options 
are available. Some authors suggest transplanting the kid-
ney intraperitoneally as a first choice for the third and subse-
quent kidney transplantation [15]. In our series, we used the 
intraperitoneal space only in 1 case. In our opinion, a retro-
peritoneal approach to the iliac fossa should always be con-
sidered as a first choice for kidney re-transplantation. First, 
the risk of twisting of the kidney on the vascular pedicle is 
greater when the graft is placed intraperitoneally. Second, 
performing a kidney biopsy is much more difficult when the 
kidney is implanted intraperitoneally. In our experience, it is 
usually quite possible to reach iliac vessels more proximally 
to the previous anastomosis. Careful patient assessment, in-
cluding a computed tomography (CT) scan visualizing the iliac 
vessels before transplantation and surgeon experience, are key 
factors to success [16].
Other options are placing the kidney in the subhepatic retroper-
itoneal space reached through a midline incision and Cattell-
Braasch maneuver or performing an orthotopic kidney trans-
plantation when the iliac fossa is inaccessible [13,17]. This 
latter technique consists, in most cases, of a left nephrectomy 
trough the lumbotomy using the native renal vein and splenic 
artery for vascular anastomosis. Musquera et al. published the 
largest series of such cases (n=84) [18].
Three prior studies have reported performance of nephrectomy 
of the failed allograft [19–21]. Nghiem published a series of 
6 cases of simultaneous pancreas and kidney (SPK) transplan-
tation at the time of kidney transplant nephrectomy [9]. He 
used the vessels of previous renal graft for anastomosis after 
verifying sufficient blood flow. No complications (including re-
nal artery stenosis) were observed and kidney function was 
excellent (average serum creatinine concentration 1.4 mg/dL) 
after an average of 39 months follow-up. LaMattina et al. pre-
sented a 9-case series of SPK re-transplantation in previous 
SPK recipients [20]. The previous transplant renal vein was re-
used in 3 cases and the previous transplant renal artery was 
reused in 1 case for the new kidney allograft anastomosis with 
good results. Chedid et al. reported a series of 6 cases of kid-
ney re-transplantation after SPK transplantation using the re-
nal vessels of the failed allograft [21]. The detailed technique 
with pre- and perioperative assessment of the remnant renal 
vessels were described with the utilization rate at the level of 
83.3% (in 5 cases the previous renal vessels were used with 
success). In some instances, the utilization of the renal ves-
sels of the failed allograft may not be possible in the event of 
severe atherosclerosis compromising the renal artery of the 
failed allograft. If the venous anastomosis is challenging due to 
thrombosis of stenosis of the iliac vein, the gonadal vein can be 
used for venous anastomosis [22]. An interesting point of view 
has been presented recently by Lejay et al. [23]. According to 
authors regarding both donor and recipient evolvement, vas-
cular surgeons should be more involved in kidney transplan-
tation when complicated vascular status is presented.
The type of donor used for re-transplantation could be an im-
portant factor. When a surgical procedure is more demanding, 
graft quality should be as high as possible. Mazzucchi et al. 
showed that kidney re-transplantations have a better graft sur-
vival with a living kidney donor [3]. One-year graft survival for 
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re-transplantation was 75% and 46% for living and deceased 
donors respectively. The impact of donor type on patient sur-
vival after kidney re-transplantation revealed no survival ben-
efits with donor kidneys from extended criteria donors [24]. 
There is lack of data regarding the use of kidneys for re-trans-
plantation from donors after circulatory death.
Although re-transplantation is more frequent accompanied by 
complications and diminished graft survival, the results are su-
perior to remaining dialysis dependent [25,26]. As compared 
to the outcomes of patients with end-stage renal failure who 
start dialysis therapy following allograft failure, transplanta-
tion of the third and subsequent kidney in the same iliac fossa 
seems to provide superior patient survival [27,28].
The limitations of our study were the small number of third 
ipsilateral kidney transplantations and the retrospective de-
sign of the study.
Conclusions
The third and subsequent kidney transplantation in the ipsi-
lateral iliac fossa is feasible and the short-term results may be 
comparable to the first and the second kidney transplant. In 
carefully selected recipients, a third or subsequent transplanta-
tion in the ipsilateral fossa is possible. Although this procedure 
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